Details of the Drug

General Information of Drug (ID: DMA6D5V)

Drug Name
SMT-19969
Synonyms Small-molecule antibacterial agents (Clostridium difficile infection), Summit
Indication
Disease Entry ICD 11 Status REF
C. difficile infection 1A04 Phase 3 [1]
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C24H16N6
Canonical SMILES
C1=CC2=C(C=C1C3=CC4=C(C=C3)N=C(N4)C5=CC=NC=C5)NC(=N2)C6=CC=NC=C6
InChI
1S/C24H16N6/c1-3-19-21(29-23(27-19)15-5-9-25-10-6-15)13-17(1)18-2-4-20-22(14-18)30-24(28-20)16-7-11-26-12-8-16/h1-14H,(H,27,29)(H,28,30)
InChIKey
UHQFBTAJFNVZIV-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
16659285
CAS Number
308362-25-6
UNII
06DX01190R
DrugBank ID
DB15308
TTD ID
D04FXY

References

1 ClinicalTrials.gov (NCT03595566) To Compare Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection (Ri-CoDIFy 2). U.S. National Institutes of Health.